The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of BLOCker sequencing (blocking oligonucleotide cycle sequencing) after ice COLD-PCR for detection of K-RAS mutations.
G. Wu
No relevant relationships to disclose
B. J. Legendre
No relevant relationships to disclose
J. Scott
No relevant relationships to disclose
S. Peterson
No relevant relationships to disclose
K. Echtenkamp
No relevant relationships to disclose
P. Eastlake
No relevant relationships to disclose
K. Richardson
No relevant relationships to disclose